Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target

Overview of attention for article published in Frontiers in oncology, April 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 9 X posts from 7 X users, with an upper bound of 36,575 followers.

RT @exosome: $enzc #ipf immune modulator may have anticancer properties by binding gp96 https://t.co/uzVt6Kz8sc

RT @exosome: $enzc #ipf immune modulator may have anticancer properties by binding gp96 https://t.co/uzVt6Kz8sc

RT @exosome: $enzc #ipf immune modulator may have anticancer properties by binding gp96 https://t.co/uzVt6Kz8sc

$enzc #ipf immune modulator may have anticancer properties by binding gp96 https://t.co/uzVt6Kz8sc

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.